BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,099 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $22,644 | +12.3% | 497 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $20,159 | -35.5% | 497 | -18.9% | 0.00% | -33.3% |
Q4 2022 | $31,245 | -5.3% | 613 | 0.0% | 0.01% | -14.3% |
Q3 2022 | $33,000 | -15.4% | 613 | 0.0% | 0.01% | -12.5% |
Q2 2022 | $39,000 | -57.1% | 613 | -47.5% | 0.01% | -52.9% |
Q1 2022 | $91,000 | -9.0% | 1,168 | 0.0% | 0.02% | -15.0% |
Q4 2021 | $100,000 | -2.9% | 1,168 | -8.6% | 0.02% | -13.0% |
Q3 2021 | $103,000 | 0.0% | 1,278 | 0.0% | 0.02% | -4.2% |
Q2 2021 | $103,000 | -4.6% | 1,278 | 0.0% | 0.02% | -14.3% |
Q1 2021 | $108,000 | +38.5% | 1,278 | +31.3% | 0.03% | +27.3% |
Q4 2020 | $78,000 | 0.0% | 973 | 0.0% | 0.02% | -12.0% |
Q3 2020 | $78,000 | -7.1% | 973 | 0.0% | 0.02% | -16.7% |
Q2 2020 | $84,000 | +16.7% | 973 | +13.5% | 0.03% | +20.0% |
Q1 2020 | $72,000 | 0.0% | 857 | 0.0% | 0.02% | 0.0% |
Q4 2019 | $72,000 | -4.0% | 857 | 0.0% | 0.02% | -10.7% |
Q3 2019 | $75,000 | +7.1% | 857 | 0.0% | 0.03% | +3.7% |
Q2 2019 | $70,000 | 0.0% | 857 | 0.0% | 0.03% | -6.9% |
Q1 2019 | $70,000 | +25.0% | 857 | 0.0% | 0.03% | +11.5% |
Q4 2018 | $56,000 | -15.2% | 857 | 0.0% | 0.03% | -3.7% |
Q3 2018 | $66,000 | +34.7% | 857 | +30.4% | 0.03% | +22.7% |
Q2 2018 | $49,000 | +14.0% | 657 | 0.0% | 0.02% | +22.2% |
Q1 2018 | $43,000 | +2.4% | 657 | 0.0% | 0.02% | +5.9% |
Q4 2017 | $42,000 | -10.6% | 657 | -12.0% | 0.02% | -15.0% |
Q3 2017 | $47,000 | -25.4% | 747 | -28.7% | 0.02% | -31.0% |
Q2 2017 | $63,000 | -11.3% | 1,047 | -23.2% | 0.03% | -12.1% |
Q1 2017 | $71,000 | +18.3% | 1,364 | 0.0% | 0.03% | +13.8% |
Q4 2016 | $60,000 | -11.8% | 1,364 | -4.9% | 0.03% | -14.7% |
Q3 2016 | $68,000 | +3.0% | 1,435 | -1.5% | 0.03% | 0.0% |
Q2 2016 | $66,000 | -19.5% | 1,457 | -27.3% | 0.03% | -26.1% |
Q1 2016 | $82,000 | -26.8% | 2,003 | -1.0% | 0.05% | -25.8% |
Q4 2015 | $112,000 | +25.8% | 2,024 | -16.2% | 0.06% | +17.0% |
Q3 2015 | $89,000 | -59.5% | 2,414 | -23.4% | 0.05% | -59.8% |
Q2 2015 | $220,000 | +24.3% | 3,150 | +30.3% | 0.13% | +13.8% |
Q4 2014 | $177,000 | -22.0% | 2,417 | -23.7% | 0.12% | -23.2% |
Q3 2014 | $227,000 | +14.1% | 3,167 | +14.8% | 0.15% | +4.9% |
Q2 2014 | $199,000 | +32.7% | 2,758 | +35.7% | 0.14% | +28.6% |
Q1 2014 | $150,000 | +7.1% | 2,032 | +0.5% | 0.11% | +115.4% |
Q4 2013 | $140,000 | +900.0% | 2,022 | +867.5% | 0.05% | +372.7% |
Q3 2013 | $14,000 | +180.0% | 209 | +194.4% | 0.01% | +175.0% |
Q2 2013 | $5,000 | – | 71 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |